A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years

NCT03275389 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

470

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human

Interventions

BIOLOGICAL: D-SUIV cH8/1N1+AS03
BIOLOGICAL: D-SUIV cH5/1N1+AS03
BIOLOGICAL: D-SUIV cH11/1N1+AS03
BIOLOGICAL: D-SUIV cH8/1N1+AS01
BIOLOGICAL: D-SUIV cH5/1N1+AS01
BIOLOGICAL: D-SUIV cH11/1N1+AS01
BIOLOGICAL: D-SUIV cH8/1N1
BIOLOGICAL: D-SUIV cH5/1N1
BIOLOGICAL: D-SUIV cH11/1N1
BIOLOGICAL: Placebo
BIOLOGICAL: Fluarix Quadrivalent

Sponsor

GlaxoSmithKline